LLY compared with ACAD: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ACADAcadia Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ACADAcadia Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only ACAD 3

STOKStoke Therapeuticssupplier

—Neurenunlistedsupplier

—Third party distributorsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ACADAcadia Pharmaceuticals Inc

21.23▼−0.03%· post 21.23

ClosedNov 6 '26

Mkt cap$3.7BRevenue$342MQ3 FY26Revenue$1.1BFY25

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

ACADAcadia Pharmaceuticals Inc

1,360.90▼−0.28%post 1,358.90

Price

21.23▼−0.03%post 21.23

$1.2T

Mkt cap

$3.7B

Q3 FY26$24.4B

Revenue

$342MQ3 FY26

FY25$65.2B

Revenue

$1.1BFY25

LLY1,360.90▼−0.28%vsACAD21.23▼−0.03%ClosedNov 6 '26